Department of Allergy, La Paz University Hospital, IdiPAZ, Madrid, Spain.
J Investig Allergol Clin Immunol. 2020;30(6):400-408. doi: 10.18176/jiaci.0562. Epub 2020 May 6.
The European Medicines Agency (EMA) defines excipients as the constituents of a pharmaceutical form apart from the active substance. Delayed hypersensitivity reactions (DHRs) caused by excipients contained in the formulation of medications have been described. However, there are no data on the prevalence of DHRs due to drug excipients. Clinical manifestations of allergy to excipients can range from skin disorders to life-threatening systemic reactions. The aim of this study was to perform a literature review on allergy to pharmaceutical excipients and to record the DHRs described with various types of medications, specifically due to the excipients contained in their formulations. The cases reported were sorted alphabetically by type of medication and excipient, in order to obtain a list of the excipients most frequently involved for each type of medication.
欧洲药品管理局(EMA)将赋形剂定义为除活性物质以外的药物制剂的组成部分。已描述了由药物制剂中所含赋形剂引起的迟发性超敏反应(DHR)。然而,由于药物赋形剂而导致 DHR 的患病率尚无数据。赋形剂过敏的临床表现范围从皮肤疾病到危及生命的全身性反应。本研究的目的是对药物赋形剂过敏进行文献综述,并记录各种类型药物中描述的 DHR,特别是由于其制剂中所含的赋形剂引起的 DHR。报告的病例按药物和赋形剂的类型按字母顺序排列,以便为每种类型的药物获得最常涉及的赋形剂列表。